Rapid test development for infectious disease states is one of the fasted growing areas of diagnostic assay development. BiosPacific is always looking for new and innovative products to bring to the market. We have expanded our portfolio to include more infectious disease markers such as Borrelia burgdorferi (Lyme), Chlamydia, CMV, Corona Virus, Dengue, HIV, Influenza A and B, Malaria HRP II, Strep A and even ZIKA. 

We also have excellent secondary antibodies for use in infectious disease serology assays. We offer IgG, IgA and IgM monoclonal antibodies as well as affinity pure polyclonals specific to different regions of the immunoglobulin proteins like Fc and H+L. 

BiosPacific can supply various antibodies and antigens for each of the disease states and we continue to develop and grow our catalog as the market grows. Please contact us to inquire about any other antibodies or proteins you may require. 

latest additions to our portfolio

• Influenza A Monoclonals• Dengue NS1 Monoclonals and Antigens• SARS-CoV-2 (COVID-19) Monoclonals and Antigens

作为卓越品质的抗体和抗原的制造商和供应商，BiosPacific拥有29多年的丰富经验，能够满足工业客户的严格要求。我们的成功很大程度上要归功于我们致力于为您的个人需求找到最有效解决方案的承诺。我们广泛的单克隆抗体，亲和纯化的多克隆抗体和用于免疫测定开发的纯化蛋白，使我们能够从可行性到生产合作提供支持。按